The Latest: Johnson & Johnson starts two-dose vaccine trial
|
November 16, 2020 3:12 PM
NEW BRUNSWICK, N.J. — Johnson & Johnson has begun a new late-stage trial of its experimental COVID-19 vaccine, this time on a two-dose regimen.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
